412
Views
6
CrossRef citations to date
0
Altmetric
Letter to the Editor

Towards developing effective hyperthermia treatment for tumours in the nasopharyngeal region

&
Pages 523-525 | Received 16 Feb 2011, Published online: 14 Jul 2011

References

  • Hua Y, Ma S, Fu Z, Hu Q, Wang L, Piao Y. Intracavity hyperthermia in nasopharyngeal cancer: A phase III clinical study. Int J Hyperthermia 2011; 27: 180–186
  • Conley BA. Treatment of advanced head and neck cancer: What lessons have we learned?. J Clin Oncol 2006; 24: 1023–1025
  • El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14: 838–847
  • Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000; 355: 949–955
  • Corry J, Peters LJ, Rischin D. Optimising the therapeutic ratio in head and neck cancer. Lancet Oncol 2010; 11: 287–291
  • Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006; 64: 57–62
  • Huilgol NG, Gupta S, Dixit R. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int J Hyperthermia 2010; 26: 21–25
  • Amichetti M, Romano M, Busana L, Bolner A, Fellin G, Pani G, Tomio L, Valdagni R. Hyperfractionated radiation in combination with local hyperthermia in the treatment of advanced squamous cell carcinoma of the head and neck: A phase I−II study. Radiother Oncol 1997; 45: 155–158
  • Franckena M, Lutgens LC, Koper PC, Kleynen CE, van der Steen-Banasik EM, Jobsen JJ, Leer JW, Creutzberg CL, Dielwart MF, van Norden Y, et al. Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: Results in 378 patients. Int J Radiat Oncol Biol Phys 2009; 73: 242–250
  • van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. The Kadota Fund International Forum 2004-clinical group consensus. Int J Hyperthermia 2008; 24: 111–122
  • Sugahara T, van der Zee J, Kampinga HH, Vujaskovic Z, Kondo M, Ohnishi T, Li G, Park HJ, Leeper DB, Ostapenko V, et al. Kadota Fund International Forum 2004. Application of thermal stress for the improvement of health, 15−18 June 2004, Awaji Yumebutai International Conference Center, Awaji Island, Hyogo, Japan. Final report. Int J Hyperthermia 2008; 24: 123–140
  • Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994; 28: 163–169
  • Valdagni R, Liu FF, Kapp DS. Important prognostic factors influencing outcome of combined radiation and hyperthermia. Int J Radiat Oncol Biol Phys 1988; 15: 959–972
  • Paulides MM, Bakker JF, Neufeld E, van der Zee J, Jansen PP, Levendag PC, van Rhoon GC. The HYPERcollar: A novel applicator for hyperthermia in the head and neck. Int J Hyperthermia 2007; 23: 567–576
  • Bakker JF, Paulides MM, Westra AH, Schippers H, Van Rhoon GC. Design and test of a 434 MHz multi-channel amplifier system for targeted hyperthermia applicators. Int J Hyperthermia 2010; 26: 158–170
  • Paulides MM, Bakker JF, Linthorst M, van der Zee J, Rijnen Z, Neufeld E, Pattynama PM, Jansen PP, Levendag PC, van Rhoon GC. The clinical feasibility of deep hyperthermia treatment in the head and neck: New challenges for positioning and temperature measurement. Phys Med Biol 2010; 55: 2465–2480
  • Dobsicek Trefna H, Vrba J, Persson M. Evaluation of a patch antenna applicator for time reversal hyperthemia. Int J Hyperthermia 2010; 26: 185–197
  • Hand JW, Lagendijk JJ, Bach Andersen J, Bolomey JC. Quality assurance guidelines for ESHO protocols. Int J Hyperthermia 1989; 5: 421–428
  • Dewhirst MW, Phillips TL, Samulski TV, Stauffer P, Shrivastava P, Paliwal B, Pajak T, Gillim M, Sapozink M, Myerson R, et al. RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Phys 1990; 18: 1249–1259
  • Lagendijk JJ, Van Rhoon GC, Hornsleth SN, Wust P, De Leeuw AC, Schneider CJ, Van Dijk JD, Van Der Zee J, Van Heek-Romanowski R, Rahman SA, Gromoll C, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998; 14: 125–133
  • Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005; 11: 5206–5214
  • Franckena M, Fatehi D, de Bruijne M, Canters RA, van Norden Y, Mens JW, van Rhoon GC, van der Zee J. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 2009; 45: 1969–1978

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.